CHARLOTTE, N.C.--(BUSINESS WIRE)--IperionX Limited (NASDAQ: IPX, ASX: IPX) (IperionX or Company) is pleased to announce the positive results of the Scoping Study (Scoping Study or Study) on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback